BHLHE41

basic helix-loop-helix family member e41, the group of Basic helix-loop-helix proteins

Basic information

Region (hg38): 12:26120030-26125037

Previous symbols: [ "BHLHB3" ]

Links

ENSG00000123095NCBI:79365OMIM:606200HGNC:16617Uniprot:Q9C0J9AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Short sleeper, familial natural, 1ADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic19679812

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the BHLHE41 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the BHLHE41 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
6
clinvar
1
clinvar
7
missense
31
clinvar
1
clinvar
2
clinvar
34
nonsense
0
start loss
0
frameshift
0
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 31 8 3

Variants in BHLHE41

This is a list of pathogenic ClinVar variants found in the BHLHE41 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
12-26122127-G-C not specified Uncertain significance (May 15, 2024)3260869
12-26122134-G-C not specified Uncertain significance (Jun 24, 2022)2401545
12-26122137-G-A not specified Uncertain significance (Jun 02, 2024)3260862
12-26122151-A-C not specified Uncertain significance (Apr 17, 2023)2537296
12-26122178-G-C not specified Uncertain significance (Sep 22, 2023)3133822
12-26122181-T-G not specified Uncertain significance (Jan 04, 2022)3133821
12-26122192-A-T BHLHE41-related disorder Likely benign (Jun 22, 2020)3041662
12-26122193-A-G not specified Likely benign (Jan 05, 2022)2347182
12-26122197-G-C not specified Uncertain significance (May 30, 2024)3260863
12-26122222-C-CGCG BHLHE41-related disorder Likely benign (May 22, 2023)3046119
12-26122233-C-T BHLHE41-related disorder Benign (Feb 18, 2020)3039300
12-26122251-G-A not specified Uncertain significance (Jan 31, 2024)3133820
12-26122283-G-T not specified Uncertain significance (Apr 26, 2023)2511137
12-26122319-G-A not specified Uncertain significance (Sep 20, 2023)3133818
12-26122344-C-T not specified Uncertain significance (Feb 01, 2023)2471449
12-26122347-G-A not specified Uncertain significance (May 20, 2024)3260864
12-26122364-G-C Short sleep, familial natural, 1 Affects (Aug 14, 2009)4530
12-26122375-C-T BHLHE41-related disorder Likely benign (May 10, 2024)3351167
12-26122399-C-G BHLHE41-related disorder Benign (Dec 03, 2019)3055569
12-26122422-G-A not specified Uncertain significance (Feb 11, 2022)2277249
12-26122431-A-G Short sleep, familial natural, 1 Affects (Mar 17, 2020)691289
12-26122435-G-C Likely benign (May 08, 2018)712110
12-26122499-T-G not specified Uncertain significance (Nov 15, 2021)2261707
12-26122509-G-A not specified Uncertain significance (Oct 30, 2023)3133817
12-26122565-C-T not specified Uncertain significance (Sep 17, 2021)2404346

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
BHLHE41protein_codingprotein_codingENST00000242728 55102
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9920.0078800000.00
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.8231581900.8320.000008882965
Missense in Polyphen3761.6760.59991832
Synonymous-0.4679185.51.060.000004321031
Loss of Function3.53014.50.006.82e-7200

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Transcriptional repressor involved in the regulation of the circadian rhythm by negatively regulating the activity of the clock genes and clock-controlled genes. Acts as the negative limb of a novel autoregulatory feedback loop (DEC loop) which differs from the one formed by the PER and CRY transcriptional repressors (PER/CRY loop). Both these loops are interlocked as it represses the expression of PER1 and in turn is repressed by PER1/2 and CRY1/2. Represses the activity of the circadian transcriptional activator: CLOCK-ARNTL/BMAL1 heterodimer by competing for the binding to E-box elements (5'-CACGTG-3') found within the promoters of its target genes. Negatively regulates its own expression and the expression of DBP and BHLHE41/DEC2. Acts as a corepressor of RXR and the RXR-LXR heterodimers and represses the ligand-induced RXRA/B/G, NR1H3/LXRA, NR1H4 and VDR transactivation activity. {ECO:0000269|PubMed:11278948, ECO:0000269|PubMed:14672706, ECO:0000269|PubMed:15193144, ECO:0000269|PubMed:15560782, ECO:0000269|PubMed:18411297, ECO:0000269|PubMed:19786558}.;
Pathway
Circadian rhythm - Homo sapiens (human);NOTCH-Ncore;BMAL1-CLOCK,NPAS2 activates circadian gene expression;Pathways in clear cell renal cell carcinoma;Circadian Clock;BMAL1:CLOCK,NPAS2 activates circadian gene expression;HIF-1-alpha transcription factor network (Consensus)

Haploinsufficiency Scores

pHI
0.168
hipred
hipred_score
ghis
0.546

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.962

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Bhlhe41
Phenotype
hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype;

Zebrafish Information Network

Gene name
bhlhe41
Affected structure
locomotion
Phenotype tag
abnormal
Phenotype quality
process quality

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;somitogenesis;Notch signaling pathway;cell population proliferation;animal organ morphogenesis;negative regulation of myotube differentiation;negative regulation of transcription by competitive promoter binding;cell differentiation;circadian regulation of gene expression;negative regulation of transcription, DNA-templated;regulation of neurogenesis
Cellular component
nucleus
Molecular function
RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II proximal promoter sequence-specific DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II activating transcription factor binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;transcription corepressor activity;protein binding;transcription factor binding;protein homodimerization activity;histone deacetylase binding;bHLH transcription factor binding;MRF binding;sequence-specific DNA binding;protein heterodimerization activity;E-box binding;sequence-specific double-stranded DNA binding